Faculty who have authored publication Twelve-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration.
Name | Title | Department | Institution |
---|---|---|---|
Thomas B. Connor MD | Professor | Ophthalmology and Visual Sciences | Medical College of Wisconsin |